Posted On: 06/08/2016 7:02:10 PM
Post# of 72446
Correcting a lie elsewhere: Legal fees to Ashcroft firm were NOT in the form of stock. The Ashcroft firm was granted one million options to BUY CTIX at 1.70/share. This means that when the stock is 17 cents higher, Rosen will be SLIGHTLY profitable. (Also, when Ashcroft exercises these options, CTIX will have a cash influx of 1.7 million.)
To me this shows that the Ashcroft firm is expecting a much, much higher stock price. If they exercised their options today (paying 1.70 for a stock trading around 1.55) they'd lose a lot of money..... so they're going to be waiting for higher prices.
They've seen all of CTIX's information about clinical trials, and they took this on when CTIX was trading at about a buck. THAT should tell people how confident the Ashcroft firm is in CTIX.
To me this shows that the Ashcroft firm is expecting a much, much higher stock price. If they exercised their options today (paying 1.70 for a stock trading around 1.55) they'd lose a lot of money..... so they're going to be waiting for higher prices.
They've seen all of CTIX's information about clinical trials, and they took this on when CTIX was trading at about a buck. THAT should tell people how confident the Ashcroft firm is in CTIX.
(3)
(0)
